Skip to content

What's happening in HIV vaccine research?

HIV-positive patients with 'dead bone' usually have other risk factors

Spanish study confirms that tenofovir-related kidney problems are rare and linked to other risk factors

Getting the most prevention and care out of programmes for the prevention of mother-to-child transmission

Abbott cuts lopinavir price to $2200 for middle-income countries; new tablet marketed as Aluvia

Denial of HIV treatment to failed asylum seekers `a human rights violation`, says BMJ

PEPFAR: Unexpected and unwanted pregnancies in women on ART highlights family planning gap

Efavirenz / Truvada three-in-one pill licensed in US as Atripla

PEPFAR: PMTCT improving but services only reaching small percentage of women in need